 |
«Radachlorin®» concentrate for production of intravenous solution 0,35%
Performance criteria of «Radachlorin®» effectiveness concluded in a number of clinical trials and observational programs, where the percentage of efficiency in comparison with other photosensitizers was much higher.
Part number:
Supplier:
RADA-PHARMA» LtdDescription
1. «Radachlorin®» the most selective and quickly accumulates in the tumour tissue, thus:
a. reduces the duration of the medical intervention;
b. reduces the cost of drugs for anaesthesia;
c. reduces the costs of providing symptomatic postoperative treatment;
d. reduces the duration of inpatient treatments.
2. «Radachlorin®» has a long shelf life, which suggests the persistence of the active substance and, accordingly, the reliability of clinical effect of the drug.
3. «Radachlorin®» has the optimal (soft) dosing mode that reduces the toxic effects of on the body drug, reducing costs of health facilities for the maintenance of patients, but also increases the effectiveness of treatment in various pathological processes.
a. reduces the duration of the medical intervention;
b. reduces the cost of drugs for anaesthesia;
c. reduces the costs of providing symptomatic postoperative treatment;
d. reduces the duration of inpatient treatments.
2. «Radachlorin®» has a long shelf life, which suggests the persistence of the active substance and, accordingly, the reliability of clinical effect of the drug.
3. «Radachlorin®» has the optimal (soft) dosing mode that reduces the toxic effects of on the body drug, reducing costs of health facilities for the maintenance of patients, but also increases the effectiveness of treatment in various pathological processes.